Specialty PACS Market is expected to attain an Outstanding Growth in Upcoming Years

09.10.2019 - 15:09 | 1760521


Artikel von marketsandmarkets

The growth in this market is driven mainly by the increasing geriatric population and subsequent growth in the incidence of various diseases, advantages associated with specialty PACS, government initiatives to increase the adoption of healthcare IT solutions, growing investments in medical imaging, rising adoption of medical imaging IT solutions, and increasing use of imaging equipment.

The global Specialty PACS market is segmented on the basis of type, deployment model, component, end user, and region. The growth in this market is driven mainly by the increasing geriatric population and subsequent growth in the incidence of various diseases, advantages associated with specialty PACS, government initiatives to increase the adoption of healthcare IT solutions, growing investments in medical imaging, rising adoption of medical imaging IT solutions, and increasing use of imaging equipment.

Based on the type, the specialty PACS market is segmented into radiology PACS, cardiology PACS, pathology PACS, ophthalmology PACS, orthopedics PACS, oncology PACS, dermatology PACS, neurology PACS, endoscopy PACS, women’s health PACS, and other specialty PACS. The radiology PACS segment accounted for the largest share of the market in 2018; however, the ophthalmology PACS segment is expected to register the highest CAGR of during the forecast period. The increasing prevalence of eye diseases and disorders, the growing number of ophthalmic surgeries performed, and technological advancements in ophthalmology devices are some of the factors driving the growth of this segment.

Download PDF Brochure(at)
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66166054
Based on the deployment model, the market is segmented into on-premise and web/cloud-based specialty PACS. The on-premise segment is expected to account for the largest share of the market. This can be attributed to the easily customizable nature of on-premise solutions, as compared to web/cloud-based specialty PACS.

Based on the end-user, the medical market is segmented into hospitals, ambulatory surgery centers (ASCs) & clinics, diagnostic imaging centers, and other end-users. The rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, increasing digitization of patient data, and rapid growth in EMR adoption are some significant factors responsible for the large share and fastest growth of this segment during the forecast period.



Request Sample Pages (at) https://www.marketsandmarkets.com/requestsampleNew.asp?id=66166054
In 2018, North America commanded the largest share of the market due to factors such as increasing medical imaging volumes and several diagnostic imaging centers, growing geriatric population, and the fast adoption of technologically advanced imaging systems. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The major players operating in this market are IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
Read More(at)
https://www.marketsandmarkets.com/PressReleases/specialty-pacs.asp

Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Leseranfragen:

PresseKontakt / Agentur:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Anmerkungen:

1760521

Kontakt-Informationen:
Vor- / Nachname: marketsandmarkets

Ansprechpartner: Mr. Shelly Singh
Stadt: northbrook
Telefon: 8886006441

Keywords (optional):
specialty-pacs-market, global-specialty-pacs-market, specialty-pacs, specialty-pacs-market-size, specialty-pacs-market-forecast, specialty-pacs-market-share, specialty-pacs-market-growth, specialty-pacs-market-trends,

Dieser Artikel wurde bisher 28 mal aufgerufen.

Verlinkung-Tipps:



Direkter Link zu diesem Artikel:




Diese Pressemeldung bookmarken bei...


Tausendreporter BlinkList del.icio.us Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.


Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht internet-intelligenz.de


[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]


Alle Artikel von marketsandmarkets RSS Feed

Mass Spectrometry : Future Forecast Indicates Impressive Growth Rate
Reaction Monitoring Market Trends Estimates High Demand by 2022
Dragonfly Therapeutics startet Phase-I/II-Studie für DF1001 bei Patienten mit fortgeschrittenen soliden Tumoren
Merck lizenziert CRISPR-Technologie zur Genomeditierung an Evotec
18-Mio-Dollar-Investition von AGC Biologics in Seattle und Dänemark stärkt globale Präsenz





Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by TopBlogs.de